Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
24
NVOS Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
28.71%
Day range:
$0.0025 - $0.0025
52-week range:
$0.0001 - $0.0990
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.00x
Volume:
3.5K
Avg. volume:
6.7K
1-year change:
-93.75%
Market cap:
$49.3K
Revenue:
$13.3M
EPS (TTM):
-$0.67
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Novo Integrated Sciences, Inc. has -- downside to fair value with a price target of -- per share.
NVOS vs. S&P 500
-
Over the past 5 trading days, Novo Integrated Sciences, Inc. has overperformed the S&P 500 by 16.33% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Novo Integrated Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Novo Integrated Sciences, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Novo Integrated Sciences, Inc. reported revenues of $3.2M.
Earnings Growth
-
Novo Integrated Sciences, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Novo Integrated Sciences, Inc. reported earnings per share of -$0.16.
Enterprise value:
4.9M
EV / Invested capital:
--
Price / LTM sales:
0.00x
EV / EBIT:
--
EV / Revenue:
0.37x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.97x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$5.5M
Return On Assets:
-33.57%
Net Income Margin (TTM):
-88.48%
Return On Equity:
-49.15%
Return On Invested Capital:
-44.59%
Operating Margin:
-48.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2023-08-31 | 2024-08-31 | |
| Income Statement | ||||||
| Revenue | $11.7M | $12.6M | $13.3M | $3.3M | $3.1M | |
| Gross Profit | $4.8M | $3.4M | $5.7M | $928.2K | $1.6M | |
| Operating Income | -$9.6M | -$8.6M | -$8.3M | -$3.1M | -$936.3K | |
| EBITDA | -$22.5M | -$5.6M | -$6.1M | -$2.5M | -$372.1K | |
| Diluted EPS | -$11.28 | -$2.05 | -$0.91 | -$0.20 | $0.26 | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $4.3M | $11.1M | -- | $4.4M | $5.4M | |
| Total Assets | $35.4M | $62M | -- | $35.6M | $32.1M | |
| Current Liabilities | $2.6M | $8.5M | -- | $7.9M | $14.6M | |
| Total Liabilities | $5.8M | $18.2M | -- | $11.1M | $17.5M | |
| Total Equity | $29.6M | $43.8M | -- | $24.5M | $14.6M | |
| Total Debt | $3.2M | $12.7M | $10.2M | $3M | $2.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2023-08-31 | 2024-08-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -$2.2M | -$5.1M | -$228.8K | -$545.9K | |
| Cash From Investing | -- | -$49.2K | -$5K | -$30.4K | -$3K | |
| Cash From Financing | -- | $763.9K | $5M | $467.5K | -$128.1K | |
| Free Cash Flow | -$6.1M | -$2.3M | -$5.1M | -$259.2K | -$548.9K | |
NVOS
Sector
Market Cap
$49.3K
$28.4M
Price % of 52-Week High
2.53%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
8.74%
-1.49%
1-Year Price Total Return
-93.75%
-16.67%
Beta (5-Year)
1.472
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$0.0023
200-day SMA
Sell
Level
$0.0060
Bollinger Bands (100)
Sell
Level
-0.0063 - 0.0137
Chaikin Money Flow
Sell
Level
-74.8M
20-day SMA
Buy
Level
$0.0018
Relative Strength Index (RSI14)
Sell
Level
48.1993
ADX Line
Buy
Level
21.3231
Williams %R
Neutral
Level
-62.5
50-day SMA
Sell
Level
$0.0050
MACD (12, 26)
Sell
Level
-0.0006
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
219.7M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-1.0214)
Buy
Beneish M-Score
(Annual)
Level (-4.0141)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (5.4361)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Novo Integrated Sciences, Inc. engages in the provision of medical services. The firm offers specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, chiropodist, neurological functions, kinesiology, and dental services. Its multi-disciplinary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation, and prevention through its clinics, affiliate clinics, retirement homes, and long-term facilities. The firm operates through the Healthcare Services and Product Sales segments. The company was founded by Michael H. Rouse on November 27, 2000 and is headquartered in Bellevue, WA.
Stock Forecast FAQ
In the current month, NVOS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NVOS average analyst price target in the past 3 months is --.
-
Where Will Novo Integrated Sciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Novo Integrated Sciences, Inc. share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Novo Integrated Sciences, Inc.?
Analysts are divided on their view about Novo Integrated Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Novo Integrated Sciences, Inc. is a Sell and believe this share price will rise from its current level to --.
-
What Is Novo Integrated Sciences, Inc.'s Price Target?
The price target for Novo Integrated Sciences, Inc. over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NVOS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Novo Integrated Sciences, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NVOS?
You can purchase shares of Novo Integrated Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Novo Integrated Sciences, Inc. shares.
-
What Is The Novo Integrated Sciences, Inc. Share Price Today?
Novo Integrated Sciences, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for Novo Integrated Sciences, Inc.. Yesterday, Novo Integrated Sciences, Inc. closed at $0.0025 per share.
-
How To Buy Novo Integrated Sciences, Inc. Stock Online?
In order to purchase Novo Integrated Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get NVOS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
NVOS
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
0.00x
1.81x
Price / LTM sales
0.00x
1.58x
Growth Metrics
NVOS
Sector
Revenue growth
24.02%
4.62%
Earnings growth
--
10.7%
Revenue (5-year growth)
7.13%
6.5%
Earnings forecast
--
-$0.21
Profitability
NVOS
Sector
Profitability FY 2024
$5.7M
$3.6M
Return on invested capital
-44.59%
-31.84%
Return on assets
-33.57%
-27.96%
Return on equity
-49.15%
-37.63%
Earnings Date
Last Earnings Date
Dec
23
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
NVOS
Sector
Total cash
$651.8K
$26.4M
Short term investments
--
$25.7M
Total assets
$32.1M
$76.9M
Long term debt
$3.3M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is down 0.27% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
